MapLight Therapeutics MPLT
NASDAQ MPLT
$7.97 -0.28 (-3.39%)
At close: Oct 23, 2026 · 4:00 PM EDT

MapLight Therapeutics (MPLT) Cash & Current Investments (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) reported Cash & Current Investments of $304.73 million for Q2 2026.

Analysis

MapLight Therapeutics (MPLT) Cash & Current Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, MapLight Therapeutics posted Cash & Current Investments of $453.1 million, up 316.5% from FY2024.

  • By year, Cash & Current Investments came in at $108.8 million in FY2024.
  • Five-year quarterly Cash & Current Investments spans a low of $108.8 million in Q4 2024 and a high of $453.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 MapLight Therapeutics 362.13 Mn 57.41 Mn - 304.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 304.73 Mn
Dec 31, 2025 453.10 Mn
Sep 30, 2025 227.20 Mn
Dec 31, 2024 108.80 Mn
API Access

MapLight Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MPLT&period=max&api_key=YOUR_API_KEY